C. S. T. PHARMA LIMITED

04212740
Active United Kingdom

Wholesale of pharmaceutical goods

115 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
C

C. S. T. PHARMA LIMITED

04212740

Wholesale of pharmaceutical goods

Founded 9 May 2001 Active United Kingdom 115 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
Accounts Submitted 2 Dec 2025 Next due 31 Jan 2027 7 months remaining
Confirmation Submitted 27 Apr 2026 Next due 11 May 2027 11 months remaining
Net assets £15M £2M 2025 year on year
Total assets £44M £11M 2025 year on year
Total Liabilities £29M £9M 2025 year on year
Charges 13
6 outstanding 7 satisfied

Contact & Details

Contact

Telephone

0800 000 0000

Website

www.example.com

Full company profile for C. S. T. PHARMA LIMITED (04212740), an active life sciences and medical technology company based in United Kingdom. Incorporated 9 May 2001. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 May → 30 Apr 2025
Type full
Next accounts 30 Apr 2026
Due by 31 Jan 2027 7 months remaining

Balance Sheet & P&L (2014–2025)

Cash in Bank

£20.65k

Decreased by £267.22k (-93%)

Net Assets

£15.29M

Increased by £1.53M (+11%)

Total Liabilities

£28.88M

Increased by £9.42M (+48%)

Turnover

£91.33M

Increased by £6.55M (+8%)

Employees

115

Decreased by 2 (-2%)

Debt Ratio

65%

Increased by 6 (+10%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Apr Year End
2024
30 Apr Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Pritchard, IanDirectorBritishEngland565 Aug 2019Active

Shareholders

Shareholders (2)

Cst Pharma Group Holdings Limited
100.0%
100
Cst Holdings (uk) Limited
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 1 Apr 2025
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Cst Holdings (uk) Limited

Ceased 1 Apr 2025

Ceased

Group Structure

Group Structure

C. S. T. PHARMA LIMITED Current Company

Charges

Charges

6 outstanding 7 satisfied

Properties

Properties

3 leasehold 3 total
AddressTenurePrice PaidDate Added
Units 5-7, Westgate Park Industrial Estate, Tintagel Way, Aldridge, Walsall (WS9 8ER) WALSALL
Leasehold-24 Feb 2021
Unit N1, Westpoint, Middlemore Lane West, Aldridge, Walsall WALSALL
Leasehold-4 Apr 2016
Unit W11, Westpoint, Middlemore Lane West, Aldridge, Walsall WALSALL
Leasehold-9 Mar 2016
Units 5-7, Westgate Park Industrial Estate, Tintagel Way, Aldridge, Walsall (WS9 8ER)
Leasehold
Added 24 Feb 2021
District WALSALL
Unit N1, Westpoint, Middlemore Lane West, Aldridge, Walsall
Leasehold
Added 4 Apr 2016
District WALSALL
Unit W11, Westpoint, Middlemore Lane West, Aldridge, Walsall
Leasehold
Added 9 Mar 2016
District WALSALL

Documents

Company Filings

DateCategoryDescriptionDocument
27 Apr 2026Confirmation StatementConfirmation statement made on 27 Apr 2026 with no updates
16 Apr 2026MortgageMortgage Satisfy Charge Full
2 Dec 2025AccountsAnnual accounts made up to 30 Apr 2025
13 May 2025Persons With Significant ControlCessation of Cst Holdings (Uk) Limited as a person with significant control on 1 Apr 2025
13 May 2025Persons With Significant ControlCst Pharma Group Holdings notified as a person with significant control
27 Apr 2026 Confirmation Statement

Confirmation statement made on 27 Apr 2026 with no updates

16 Apr 2026 Mortgage

Mortgage Satisfy Charge Full

2 Dec 2025 Accounts

Annual accounts made up to 30 Apr 2025

13 May 2025 Persons With Significant Control

Cessation of Cst Holdings (Uk) Limited as a person with significant control on 1 Apr 2025

13 May 2025 Persons With Significant Control

Cst Pharma Group Holdings notified as a person with significant control

Recent Activity

Latest Activity

Confirmation statement made on 27 Apr 2026 with no updates

1 months ago on 27 Apr 2026

Mortgage Satisfy Charge Full

1 months ago on 16 Apr 2026

Annual accounts made up to 30 Apr 2025

6 months ago on 2 Dec 2025

Cessation of Cst Holdings (Uk) Limited as a person with significant control on 1 Apr 2025

1 years ago on 13 May 2025

Cst Pharma Group Holdings notified as a person with significant control

1 years ago on 13 May 2025